Gene-edited crops pioneer Calyxt crashes, giving the lie to deregulation claims
By Jonathan Matthews and Claire Robinson,
GMWatch
| 10. 02. 2022
Kelly Sikkema for Unsplash
As governments around the world are lobbied by industry with claims gene editing can deliver rapid solutions to our food and farming problems — they just need deregulation, the company that pioneered gene-edited crops in the lax regulatory environment of the US is considering selling its assets amid plummeting revenues and share prices.
Calyxt was the first to market gene-edited soybeans in 2019. The beans are genetically engineered to produce high oleic oil. You might think anyone wanting high oleic oils could just buy olive oil but Calyxt was primarily targeting the processed foods markets by promoting its oil as a healthier alternative to commodity soybean oils that produce trans fats when cooked at high temperatures, though no research directly showed health benefits.
Calyxt was also reported to have other “consumer-focused” gene-edited foods in the pipeline, like high fibre wheat and reduced browning potatoes.
Rapidly developing disruptive technology
The company told investors that as a gene editing pioneer accelerating product development, “this is an exciting time for Calyxt and a rapidly developing disruptive plant-based technology story”...
Related Articles
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Carolyn Riley Chapman and Nirvan Bhatia, Hastings Bioethics Forum | 03.12.2026
Last year, researchers saved an infant named KJ from a life-threatening rare metabolic disorder using a customized gene editing therapy. This was the first time that an individualized gene therapy was used to treat a human patient, and it has...